Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein V (CENP-V) is a centromere- and spindle-associated protein implicated in chromosome segregation and spindle formation during mitosis and meiosis[3][1][4]. CENP-V contains a C-terminal GFA-like enzymatic domain that can bind glutathione and is related to bacterial detoxifying enzymes[5][1]. It plays an essential architectural role for the primary constriction of mitotic chromosomes and stabilization of the chromosomal passenger complex (CPC); its proper levels are crucial for chromatin condensation and cell cycle progression[1][5]. Depletion of CENP-V results in major mitotic defects, including chromosome misalignment, altered chromatin states, and rapid cell death, highlighting its vital function for genomic stability[1][4][5]. No drugs directly target CENP-V and it is not classified as a therapeutic target, but its dysfunction is relevant for diseases linked to chromosome segregation defects (such as certain cancers and reproductive aging)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein V (CENP-V).